326 related articles for article (PubMed ID: 31941804)
1. Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis.
Chen S; Blijdorp IC; van Mens LJJ; Bowcutt R; Latuhihin TE; van de Sande MGH; Shaw S; Yeremenko NG; Baeten DLP
J Rheumatol; 2020 Nov; 47(11):1606-1613. PubMed ID: 31941804
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.
Zrioual S; Ecochard R; Tournadre A; Lenief V; Cazalis MA; Miossec P
J Immunol; 2009 Mar; 182(5):3112-20. PubMed ID: 19234208
[TBL] [Abstract][Full Text] [Related]
4. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis.
Samarpita S; Ganesan R; Rasool M
Toxicol Appl Pharmacol; 2020 Mar; 391():114917. PubMed ID: 32044269
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
van Baarsen LG; Lebre MC; van der Coelen D; Aarrass S; Tang MW; Ramwadhdoebe TH; Gerlag DM; Tak PP
Arthritis Res Ther; 2014 Aug; 16(4):426. PubMed ID: 25146432
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis.
Möller B; Kukoc-Zivojnov N; Kessler U; Rehart S; Kaltwasser JP; Hoelzer D; Kalina U; Ottmann OG
Rheumatology (Oxford); 2001 Mar; 40(3):302-9. PubMed ID: 11285378
[TBL] [Abstract][Full Text] [Related]
7. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis.
Cañete JD; Celis R; Yeremenko N; Sanmartí R; van Duivenvoorde L; Ramírez J; Blijdorp I; García-Herrero CM; Pablos JL; Baeten DL
Arthritis Res Ther; 2015 Jul; 17(1):173. PubMed ID: 26156866
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
Hot A; Miossec P
Ann Rheum Dis; 2011 May; 70(5):727-32. PubMed ID: 21345813
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis.
Xu X; Davelaar N; Mus AM; Asmawidjaja PS; Hazes JMW; Baeten DLP; Vis M; Bisoendial RJ; Prens EP; Lubberts E
Arthritis Rheumatol; 2020 Aug; 72(8):1303-1313. PubMed ID: 32243724
[TBL] [Abstract][Full Text] [Related]
10. mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation
Chen S; van Tok MN; Knaup VL; Kraal L; Pots D; Bartels L; Gravallese EM; Taurog JD; van de Sande M; van Duivenvoorde LM; Baeten DL
Front Immunol; 2019; 10():2344. PubMed ID: 32194539
[No Abstract] [Full Text] [Related]
11. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
[TBL] [Abstract][Full Text] [Related]
12. Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type.
Noack M; Beringer A; Miossec P
Front Immunol; 2019; 10():1726. PubMed ID: 31396230
[No Abstract] [Full Text] [Related]
13. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.
Ichise Y; Saegusa J; Tanaka-Natsui S; Naka I; Hayashi S; Kuroda R; Morinobu A
Cells; 2020 Jul; 9(7):. PubMed ID: 32674360
[TBL] [Abstract][Full Text] [Related]
14. Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells.
Chan A; Filer A; Parsonage G; Kollnberger S; Gundle R; Buckley CD; Bowness P
Arthritis Rheum; 2008 Mar; 58(3):707-17. PubMed ID: 18311795
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
Lavocat F; Osta B; Miossec P
Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
[TBL] [Abstract][Full Text] [Related]
17. Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis.
Yeremenko N
Curr Opin Rheumatol; 2021 Jul; 33(4):333-340. PubMed ID: 34001692
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint.
Yeremenko N; Zwerina K; Rigter G; Pots D; Fonseca JE; Zwerina J; Schett G; Baeten D
Arthritis Rheumatol; 2015 May; 67(8):2071-5. PubMed ID: 25941031
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.
Agarwal S; Misra R; Aggarwal A
J Rheumatol; 2008 Mar; 35(3):515-9. PubMed ID: 18203309
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis.
Barthel C; Yeremenko N; Jacobs R; Schmidt RE; Bernateck M; Zeidler H; Tak PP; Baeten D; Rihl M
Arthritis Res Ther; 2009; 11(3):R82. PubMed ID: 19490633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
